3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
5
Breast Neoplasms
5
Stomach Neoplasms
3
Neoplasms
3
Malnutrition
3
Lung Neoplasms
3
Diarrhea
3
Mucositis
2
Enteritis
2
Chalazion
2
Carcinoma, Hepatocellular
2
Thyroid Neoplasms
1
Squamous Intraepithelial Lesions
1
Smoldering Multiple Myeloma
1
Psychological Well-Being
1
Polycystic Ovary Syndrome
1
Periampullary Carcinoma Nos
1
Pelvic Neoplasms
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Neoplasms, Second Primary
1
Muscle Invasive Bladder Cancer (MIBC)
1
Multiple Myeloma
1
Motor Activity
1
Monoclonal Gammopathy of Undetermined Significance
1
Liver Cirrhosis
1
Limited Stage Small Cell Lung Cancer
1
Laryngeal Neoplasms
1
Inflammation
1
Infections
1
Interventions
Fluorouracil
14
Radiotherapy
11
Mitomycin
9
Radiation
8
Capecitabine
8
Surveys and Questionnaires
6
Drug Therapy
6
Cisplatin
6
pembrolizumab
5
Paclitaxel
4
Magnetic Resonance Spectroscopy
4
Irinotecan
3
Immune Checkpoint Inhibitors
3
Cetuximab
3
Carboplatin
3
Biopsy
3
tislelizumab
2
durvalumab
2
atezolizumab
2
aldesleukin
2
Therapeutics
2
Specimen Handling
2
Papillomavirus Vaccines
2
Oxaliplatin
2
Observation
2
Nivolumab
2
Cyclophosphamide
2
Blood Specimen Collection
2
Adoptive Transfer
2
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Anus Neoplasms
×
Probiotics
×
Clear all
NCT03870607
2023-01-17
BISQUIT
AC Camargo Cancer Center
Phase 2
Unknown
75 enrolled